Task: Translation
Input (Spanish): The present invention relates to an ICOS binding protein or antigen binding portion thereof that is an agonist to human ICOS and does not induce complement, ADCC, or CDC when placed in contact with a T cell in vivo and methods of treating cancer, infectious disease and/or sepsis with said ICOS binding protein or antigen binding portion thereof.
Output (English): La presente invención se refiere a una proteína de unión a ICOS o porción de unión al antígeno de la misma que es un agonista para ICOS humana y no induce complemento, ADCC o CDC cuando se pone en contacto con un linfocito T in vivo.